Ventricular Rate Regularization for Improved Quality of Life in Patients With CHF and AF
| Status: | Completed |
|---|---|
| Conditions: | Atrial Fibrillation, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 2/4/2013 |
| Start Date: | November 2007 |
| End Date: | November 2009 |
| Contact: | Melissa Mangum, BS |
| Email: | melissa.mangum@ucdmc.ucdavis.edu |
| Phone: | 916-734-7199 |
Randomized Study of Ventricular Rate Regularization for Improved Quality of Life in Patients With Congestive Heart Failure and Atrial Fibrillation.
Single center investigator initiated sponsored by Guidant Boston Scientific Corp. to
evaluate the benefit of ventricular rate regularization (VRR) in patients with congestive
heart failure (CHF) and significant atrial fibrillation (AF) burden.
Inclusion Criteria:
- Be between 18-85 years old
- Be willing and able to give informed consent
- Patient currently has a CRT-D or ICD with > 20% atrial fibrillation burden as
recorded by defibrillator follow up report or a history of atrial fibrillation prior
to implant.
- Patient has the ability to complete a Six minute walk test with the only limiting
factors to be fatigue or shortness of breath.
Exclusion Criteria:
- Expected mortality less than 6 months due to non-cardiac causes.
- Pregnant women.
- Creatinine greater than or equal to 2.5 mg/dl.
- Anemia (HCT less than 30)
- COPD causing significant dyspnea
- Orthopedic problems affecting 6 minute walk.
We found this trial at
1
site
Click here to add this to my saved trials
